News & Events

Latest Blog Posts & Events

How Do Black People with Cancer View Clinical Research?
A small study may help explain why some Black people are hesitant to enroll in clinical trials.
New Combo Treatment Boosts Hodgkin Lymphoma Cures
Adding the immunotherapy drug nivolumab to chemo was more effective than the current standard treatment.
Comparing Lymph Node Surgeries for Bladder Cancer
In a clinical trial, extended lymph node surgery in people with bladder cancer didn’t improve survival compared with standard surgery.

Latest Press Releases

Researchers uncover new role of mutant RAS proteins in some of the deadliest cancers
- November 11, 2024
A new study led by NCI researchers shows that mutant RAS proteins help release a nuclear protein from a complex transported from the nucleus to the cytoplasm, kicking off a series of events that lead to the breakdown of a tumor suppressor protein.
NIH-funded scientists uncover clues to precancer and tumor biology
- October 30, 2024
New studies released by NCI’s Human Tumor Atlas Network explore the role of the tumor microenvironment and the immune system in promoting the spread of cancer and its resistance to treatment. The studies appear across several Nature journals.
NIH clinical trial will test precision medicine treatments for myeloid cancers
- October 23, 2024
NCI has launched myeloMATCH, a precision medicine treatment trial that will test treatment combinations targeting specific genetic changes in people with acute myeloid leukemia and myelodysplastic syndromes.
New cancer diagnoses did not rebound as expected following pandemic
- September 24, 2024
While new cancer diagnoses largely returned to pre-pandemic levels in 2021, they don’t account for the missed diagnoses in early 2020 that resulted from disruptions in cancer screening and other medical care.
NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry
- September 16, 2024
A new study suggests, for men with West African genetic ancestry, living in a disadvantaged neighborhood was associated with a higher risk of prostate cancer. The researchers posit that chronic stress—such as from racial profiling, housing discrimination, and exposure to violence—may be a possible driver.